Results 81 to 90 of about 24,031,398 (300)

Data augmentation scheme for federated learning with non-IID data

open access: yesTongxin xuebao, 2023
To solve the problem that the model accuracy remains low when the data are not independent and identically distributed (non-IID) across different clients in federated learning, a privacy-preserving data augmentation scheme was proposed.Firstly, a data ...
Lingtao TANG, Di WANG, Shengyun LIU
doaj   +2 more sources

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Spectral image data aggregation for multisource data augmentation

open access: yesEuropean Journal of Remote Sensing
Multispectral and hyperspectral images are increasingly popular in different research fields, such as remote sensing, astronomical imaging, or precision agriculture.
R. I. Luca, A. Baicoianu, I. C. Plajer
doaj   +1 more source

Adversarial Data Augmentation on Breast MRI Segmentation

open access: yesApplied Sciences, 2021
The scarcity of balanced and annotated datasets has been a recurring problem in medical image analysis. Several researchers have tried to fill this gap employing dataset synthesis with adversarial networks (GANs).
João F. Teixeira   +5 more
doaj   +1 more source

Data Augmentation and Pretraining for Template-Based Retrosynthetic Prediction in Computer-Aided Synthesis Planning [PDF]

open access: yes, 2020
This work presents efforts to augment the performance of data-driven machine learning algorithms for reaction template recommendation used in computer-aided synthesis planning software.
Brian, Barnes   +3 more
core   +2 more sources

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Natural Data-augmentation for Skin Lesions (ISIC-2017 Challenge Dataset)

open access: yes, 2019
Data augmentation techniques may mitigate many limitations of datasets, such as imbalanced data among the classes of skin lesions and heterogeneous sources of data, by adding augmented samples with different image transformations, such as rotation ...
Goyal, M (via Mendeley Data)
core   +2 more sources

SeisAug: A data augmentation python toolkit

open access: yesApplied Computing and Geosciences
A common limitation in applying any deep learning and machine learning techniques is the limited labelled dataset which can be addressed through Data augmentation (DA). SeisAug is a DA python toolkit to address this challenge in seismological studies. DA.
D. Pragnath   +3 more
doaj   +1 more source

The Data Augmentation Algorithm

open access: yes
The data augmentation (DA) algorithms are popular Markov chain Monte Carlo (MCMC) algorithms often used for sampling from intractable probability distributions. This review article comprehensively surveys DA MCMC algorithms, highlighting their theoretical foundations, methodological implementations, and diverse applications in frequentist and Bayesian ...
Roy, Vivekananda   +2 more
openaire   +2 more sources

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy